StockComparison Logo
vs

IBO vs MREO

Comparison between NYSE AMEX LISTED TEST STOCK FOR CTS CQS (IBO, Company) and Mereo Biopharma Group Plc (MREO, Company).

Both IBO and MREO are from the Healthcare sector.

IBO vs MREO - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
IBO
$53M
MREO
$53M
Max Drawdown
Winner
IBO
92.70%
MREO
96.35%
Sharpe Ratio
Winner
IBO
0.78
MREO
-0.29
5Y Beta
Winner
IBO
-0.90
MREO
1.26
Industry
IBO
Biotechnology
MREO
Biotechnology
P/E Ratio
Winner
IBO
-4.33
MREO
-1.27
Debt to Equity
IBO
0.00%
MREO
0.00%
Free Cash Flow Yield
Winner
IBO
-3.16%
MREO
-51.14%
P/S Ratio
IBO
1437.62
Winner
MREO
109.82
P/B Ratio
IBO
4.83
Winner
MREO
1.60

IBO vs MREO - Historical Returns

Returns include dividend reinvestment.

1M
IBO
-12.91%
Winner
MREO
+12.38%
3M
Winner
IBO
-12.84%
MREO
-19.90%
6M
Winner
IBO
+22.27%
MREO
-84.80%
1Y
Winner
IBO
+12.45%
MREO
-87.27%
5Y(CAGR)
IBO
N/A
MREO
-38.63%
Max(CAGR)
IBO
-59.83%
Winner
MREO
-34.70%

IBO vs MREO - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearIBOMREO
2026+8.00%-38.64%
2025-67.21%-87.82%
2024-45.90%+52.17%
2023N/A+212.16%
2022N/A-55.88%
2021N/A-54.80%
2020N/A+11.53%
2019N/A-49.54%

IBO vs MREO Drawdown Comparison

The maximum drawdown for IBO was -92.70%, occurring on Jun 20, 2025. This drawdown has not yet recovered.

The maximum drawdown for MREO was -96.35%, occurring on May 6, 2026. This drawdown has not yet recovered.

The current IBO drawdown is -88.71%. The current MREO drawdown is -95.18%.

RankIBOMREO
#1-92.70%
Mar 21, 2025 - Jun 20, 2025
-96.35%
Apr 24, 2019 - May 6, 2026
#2-82.57%
Nov 18, 2024 - Mar 21, 2025
N/A
#3-53.36%
Sep 16, 2024 - Nov 4, 2024
N/A
#4-13.45%
Nov 8, 2024 - Nov 15, 2024
N/A
#5-4.45%
Nov 4, 2024 - Nov 7, 2024
N/A

Correlation

Correlation between IBO and MREO is 0.75 which considered as a strong positive correlation - the stocks tend to move together.

0.75
-101

Select Stocks to Compare